Enhabit (EHAB) Stock Overview
Provides home health and hospice services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for EHAB from our risk checks.
EHAB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Enhabit, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.19 |
| 52 Week High | US$10.91 |
| 52 Week Low | US$6.47 |
| Beta | 1.3 |
| 1 Month Change | 21.33% |
| 3 Month Change | -21.63% |
| 1 Year Change | -2.73% |
| 3 Year Change | -45.55% |
| 5 Year Change | n/a |
| Change since IPO | -67.24% |
Recent News & Updates
Recent updates
Enhabit, Inc. (NYSE:EHAB) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Jul 03
Enhabit: Debt Reduction And Divestitures, But Not That Cheap Anymore (Rating Downgrade)
Jun 27Enhabit (NYSE:EHAB) Has A Pretty Healthy Balance Sheet
Jun 14
US Home Health Demand And Value-Based Care Will Create Future Opportunities
Structural trends and targeted expansion in underserved markets are driving sustained revenue growth and building a reliable recurring revenue base.Returns On Capital At Enhabit (NYSE:EHAB) Paint A Concerning Picture
May 09Enhabit, Inc.'s (NYSE:EHAB) Revenues Are Not Doing Enough For Some Investors
Apr 09Enhabit: Healthcare Predictive Analytics, FCF, Very Undervalued
Feb 03Is Enhabit (NYSE:EHAB) A Risky Investment?
Dec 14Returns On Capital At Enhabit (NYSE:EHAB) Paint A Concerning Picture
Nov 07Is Enhabit (NYSE:EHAB) Using Too Much Debt?
Jul 17Is Enhabit Dead? Not Quite Yet
Jul 15Enhabit (NYSE:EHAB) Could Be At Risk Of Shrinking As A Company
Jun 19An Intrinsic Calculation For Enhabit, Inc. (NYSE:EHAB) Suggests It's 42% Undervalued
May 10Here's What Analysts Are Forecasting For Enhabit, Inc. (NYSE:EHAB) After Its Annual Results
Mar 09The Market Doesn't Like What It Sees From Enhabit, Inc.'s (NYSE:EHAB) Revenues Yet
Mar 05Enhabit (NYSE:EHAB) Could Be Struggling To Allocate Capital
Feb 09A Look At The Intrinsic Value Of Enhabit, Inc. (NYSE:EHAB)
Oct 04Enhabit: 40% Slump In Pre-Tax Earnings, Payer Headwinds Remain In Situ, Reiterate Hold
Aug 18Enhabit: Difficult To Justify At 20x Earnings, Reiterate Hold
Jun 07An Intrinsic Calculation For Enhabit, Inc. (NYSE:EHAB) Suggests It's 24% Undervalued
May 31Enhabit beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 15Enhabit: Difficult Time Ahead According To Market Generated Data (Technical Analysis)
Jan 29Enhabit, Inc.'s (NYSE:EHAB) Intrinsic Value Is Potentially 91% Above Its Share Price
Jan 19Enhabit, Inc.'s (NYSE:EHAB) Shares Lagging The Market But So Is The Business
Dec 07Jana Partners adds stakes in Momentive, Freshpet, Enhabit in Q3, exits Conagra
Nov 14Shareholder Returns
| EHAB | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.8% | 1.3% | 0.5% |
| 1Y | -2.7% | -27.7% | 15.9% |
Return vs Industry: EHAB exceeded the US Healthcare industry which returned -27.7% over the past year.
Return vs Market: EHAB underperformed the US Market which returned 15.7% over the past year.
Price Volatility
| EHAB volatility | |
|---|---|
| EHAB Average Weekly Movement | 8.2% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EHAB has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: EHAB's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 10,700 | Barb Jacobsmeyer | www.ehab.com |
Enhabit, Inc. provides home health and hospice services in the United States. The company’s home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.
Enhabit, Inc. Fundamentals Summary
| EHAB fundamental statistics | |
|---|---|
| Market cap | US$415.15m |
| Earnings (TTM) | -US$133.20m |
| Revenue (TTM) | US$1.04b |
Is EHAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EHAB income statement (TTM) | |
|---|---|
| Revenue | US$1.04b |
| Cost of Revenue | US$530.50m |
| Gross Profit | US$507.30m |
| Other Expenses | US$640.50m |
| Earnings | -US$133.20m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.63 |
| Gross Margin | 48.88% |
| Net Profit Margin | -12.83% |
| Debt/Equity Ratio | 81.2% |
How did EHAB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/25 05:41 |
| End of Day Share Price | 2025/08/22 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Enhabit, Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joanna Sylvia Gajuk | BofA Global Research |
| Jason Cassorla | Citigroup Inc |
| Albert J. Rice | Credit Suisse |